Literature DB >> 2810674

Incidence of human immunodeficiency virus seroconversion in US Navy and Marine Corps personnel, 1986 through 1988.

F C Garland1, D L Mayers, T M Hickey, M R Miller, E K Shaw, E D Gorham, L R Bigbee, M M McNally.   

Abstract

From 1986 through 1988, the US Navy and US Marine Corps administered 1,956,631 enzyme-linked immunosorbent assay screening tests for antibodies to the human immunodeficiency virus to 1,070,511 active-duty enlisted and officer personnel. This study identified all persons who had an initial test with negative results. This population was then followed up and those who later tested positive for human immunodeficiency virus were identified as seroconverters. There were 582 seroconversions identified from a total of 987,479 person-years at risk. The age adjusted seroconversion rate and 95% Poisson confidence intervals for navy personnel was 0.69 per 1000 person-years (95% confidence interval, 0.63 to 0.76). Age-adjusted rates in men were 5.0 times those of women. Age-adjusted rates in blacks were 3.7 times those of whites. The age-adjusted seroconversion rate in Marine Corps personnel was 0.28 per 1000 person-years (95% confidence interval, 0.22 to 0.36). Similar demographic patterns were present in the Marine Corps and the US Navy. This study is one of the first reports of incidence of human immunodeficiency virus seroconversion by demographic characteristics in a large, young, and apparently healthy population.

Entities:  

Mesh:

Year:  1989        PMID: 2810674

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  4 in total

1.  Decline in human immunodeficiency virus seropositivity and seroconversion in US Navy enlisted personnel: 1986 to 1989. Navy HIV Working Group.

Authors:  F C Garland; E D Gorham; S O Cunnion; M R Miller; L L Balazs
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

2.  A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee.

Authors:  A M McDonald; D M Gertig; N Crofts; J M Kaldor
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

Review 3.  Murine AIDS: a model for the human disease or a distinct entity?

Authors:  R K Cunnigham; H R Thacore; P Zhou; R Terzian; S Nakeeb; M B Zaleski
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 4.  Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.

Authors:  Christopher L Perdue; Angelia A Eick Cost; Mark V Rubertone; Luther E Lindler; Sharon L Ludwig
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.